<?xml version="1.0" encoding="UTF-8"?>
<p>For systemic 
 <italic>in vivo</italic> CD8
 <sup>+</sup> T cell depletion, published protocols [
 <xref rid="ppat.1008036.ref071" ref-type="bibr">71</xref>, 
 <xref rid="ppat.1008036.ref072" ref-type="bibr">72</xref>] were adopted as follows. BALB/c mice were i.p. injected with 200 μg anti-CD8α (αCD8: clone: YTS 169.4) or isotype antibody (Rat IgG2b: clone: LTF-2; Bio X Cell) one day before IAV challenge. To deplete mucosal CD8
 <sup>+</sup> T cells in the lungs, BALB/c mice were i.n. administered 10 μg αCD8 or IgG2b in 20 μl of PBS one day before IAV challenge [
 <xref rid="ppat.1008036.ref040" ref-type="bibr">40</xref>].
</p>
